Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 1
2011 1
2013 2
2016 2
2017 3
2021 4
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Dytfeld D, Wróbel T, Jamroziak K, Kubicki T, Robak P, Walter-Croneck A, Czyż J, Tyczyńska A, Druzd-Sitek A, Giannopoulos K, Nowicki A, Szczepaniak T, Łojko-Dankowska A, Matuszak M, Gil L, Puła B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski Ł, Końska A, Zaucha JM, Walewski J, Mikulski D, Czabak O, Robak T, Lahoud OB, Zonder JA, Griffith K, Stefka A, Major A, Derman BA, Jakubowiak AJ. Dytfeld D, et al. Among authors: matuszak m. Lancet Oncol. 2023 Feb;24(2):139-150. doi: 10.1016/S1470-2045(22)00738-0. Epub 2023 Jan 12. Lancet Oncol. 2023. PMID: 36642080 Free PMC article. Clinical Trial.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Kubicki T, Dytfeld D, Wróbel T, Jamroziak K, Robak P, Czyż J, Tyczyńska A, Druzd-Sitek A, Giannopoulos K, Szczepaniak T, Łojko-Dankowska A, Matuszak M, Gil L, Puła B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski Ł, Zaucha JM, Mikulski D, Czabak O, Lahoud OB, Stefka A, Derman BA, Jakubowiak AJ. Kubicki T, et al. Among authors: matuszak m. Br J Haematol. 2023 Dec;203(5):792-802. doi: 10.1111/bjh.19097. Epub 2023 Sep 10. Br J Haematol. 2023. PMID: 37691005 Clinical Trial.
Spray curtains as devices for surface spraying during the SARS-CoV-2 pandemic.
Ochowiak M, Włodarczak S, Krupińska A, Matuszak M, Fedak W, Ligus G, Kołodziej S, Wasilewska B. Ochowiak M, et al. Among authors: matuszak m. Environ Res. 2022 Apr 15;206:112562. doi: 10.1016/j.envres.2021.112562. Epub 2021 Dec 15. Environ Res. 2022. PMID: 34921823 Free PMC article.
Microscopic Droplet Size Analysis (MDSA) of "Five Thieves' Oil" (Olejek Pięciu Złodziei) Essential Oil after the Nebulization Process.
Smułek W, Jarzębski M, Ochowiak M, Matuszak M, Kaczorek J, Stangierski J, Pawlicz J, Drobnik P, Nowakowski PT, Dyrda-Muskus J, Fiutak G, Gorzelak M, Ray SS, Pal K. Smułek W, et al. Among authors: matuszak m. Molecules. 2023 May 26;28(11):4368. doi: 10.3390/molecules28114368. Molecules. 2023. PMID: 37298844 Free PMC article.
Flow Rate Control by Means of Flow Meter and PLC Controller.
Włodarczak S, Ochowiak M, Doligalski M, Kwapisz B, Krupińska A, Mrugalski M, Matuszak M. Włodarczak S, et al. Among authors: matuszak m. Sensors (Basel). 2021 Sep 14;21(18):6153. doi: 10.3390/s21186153. Sensors (Basel). 2021. PMID: 34577360 Free PMC article.
20 results